CN Patent

CN108003161B — 神经营养因子酪氨酸激酶受体抑制剂

Assigned to Capital Pharmaceutical Holdings Beijing Co ltd · Expires 2020-10-09 · 6y expired

What this patent protects

本发明提供了一种神经营养因子酪氨酸激酶受体抑制剂。本发明提供的酪氨酸激酶受体抑制剂具有三环母核结构，能够抑制Trk激酶的活性，可以治疗哺乳动物由Trk激酶介导的疾病。

USPTO Abstract

本发明提供了一种神经营养因子酪氨酸激酶受体抑制剂。本发明提供的酪氨酸激酶受体抑制剂具有三环母核结构，能够抑制Trk激酶的活性，可以治疗哺乳动物由Trk激酶介导的疾病。

Drugs covered by this patent

larotrectinib-sulfate (LAROTRECTINIB SULFATE)

Patent Metadata

Patent number: CN108003161B
Jurisdiction: CN
Classification: —
Expires: 2020-10-09
Drug substance claim: No
Drug product claim: No
Assignee: Capital Pharmaceutical Holdings Beijing Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.